PALVELLA THERAPEUTICS, INC. — Director's Dealing 2017

Jan 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PIERIS PHARMACEUTICALS, INC. (PIRS)
CIK: 0001583648
Period of Report: 2017-01-25

Reporting Person: Prelack Steven (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-25	Stock Option (right to buy)	$2.01	A	20000	Acquired	2027-01-25	Common Stock (20000)	Direct

Footnotes

F1: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017.